Naringin Dihydrochalcone (CAS 18916-17-1): Natural Sweetness Meets Scientific Innovation
Naringin Dihydrochalcone, catalogued under CAS 18916-17-1, represents a significant advancement in the field of sweeteners and functional ingredients. Sourced from naringin, a naturally occurring bitter compound in citrus fruits, this derivative has been chemically modified to deliver an exceptionally intense sweetness, reportedly 500-700 times that of sucrose. This makes it a prime candidate for the growing demand for low-calorie, sugar-free alternatives. NINGBO INNO PHARMCHEM CO.,LTD. is a leading Naringin Dihydrochalcone supplier, offering this compound with the highest standards of purity.
The development of Naringin Dihydrochalcone addresses the need for palatable and healthy sweetening agents. Its synthesis transforms the bitter profile of naringin into a clean, pleasant taste, making it suitable for a wide range of applications. The compound’s identity as a phloretin glycoside contributes to its unique properties, positioning it as a valuable ingredient for product developers. Securing a reliable Naringin Dihydrochalcone manufacturer is crucial for consistent product quality.
Beyond its sweetening prowess, Naringin Dihydrochalcone exhibits valuable bioactivity, notably its function as a CYP enzyme inhibitor. Cytochrome P450 enzymes are pivotal in the metabolism of many compounds, including pharmaceuticals. Inhibition of these enzymes by Naringin Dihydrochalcone is of great interest to researchers in pharmacology and toxicology, aiding in the study of drug interactions and metabolic pathways. The ease with which one can order Naringin Dihydrochalcone facilitates such scientific exploration.
Moreover, Naringin Dihydrochalcone plays a role in lipid metabolism regulation. It has been shown to inhibit HMG-CoA reductase, a key enzyme in cholesterol synthesis, and ACAT enzymes involved in cholesterol esterification. These properties suggest potential health benefits, particularly in areas related to cardiovascular health and lipid management. The appeal of Naringin Dihydrochalcone purchase extends to these health-focused applications.
The versatility of Naringin Dihydrochalcone is evident across industries. In the food and beverage sector, it allows for the creation of low-sugar products without compromising taste. Its bitterness-masking capability is also a significant advantage in confectioneries, dairy products, and even oral care items like toothpaste. In pharmaceuticals, it can improve the palatability of medicinal formulations, enhancing patient compliance.
NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to being your trusted source for high-quality Naringin Dihydrochalcone. Our commitment to excellence in manufacturing and supply ensures that our clients receive an ingredient that meets rigorous specifications. Whether you are innovating in the food industry, conducting critical biomedical research, or developing new pharmaceutical products, Naringin Dihydrochalcone offers a unique combination of sweetness and biological function. Partner with NINGBO INNO PHARMCHEM CO.,LTD. to harness the potential of this exceptional citrus-derived compound.
The development of Naringin Dihydrochalcone addresses the need for palatable and healthy sweetening agents. Its synthesis transforms the bitter profile of naringin into a clean, pleasant taste, making it suitable for a wide range of applications. The compound’s identity as a phloretin glycoside contributes to its unique properties, positioning it as a valuable ingredient for product developers. Securing a reliable Naringin Dihydrochalcone manufacturer is crucial for consistent product quality.
Beyond its sweetening prowess, Naringin Dihydrochalcone exhibits valuable bioactivity, notably its function as a CYP enzyme inhibitor. Cytochrome P450 enzymes are pivotal in the metabolism of many compounds, including pharmaceuticals. Inhibition of these enzymes by Naringin Dihydrochalcone is of great interest to researchers in pharmacology and toxicology, aiding in the study of drug interactions and metabolic pathways. The ease with which one can order Naringin Dihydrochalcone facilitates such scientific exploration.
Moreover, Naringin Dihydrochalcone plays a role in lipid metabolism regulation. It has been shown to inhibit HMG-CoA reductase, a key enzyme in cholesterol synthesis, and ACAT enzymes involved in cholesterol esterification. These properties suggest potential health benefits, particularly in areas related to cardiovascular health and lipid management. The appeal of Naringin Dihydrochalcone purchase extends to these health-focused applications.
The versatility of Naringin Dihydrochalcone is evident across industries. In the food and beverage sector, it allows for the creation of low-sugar products without compromising taste. Its bitterness-masking capability is also a significant advantage in confectioneries, dairy products, and even oral care items like toothpaste. In pharmaceuticals, it can improve the palatability of medicinal formulations, enhancing patient compliance.
NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to being your trusted source for high-quality Naringin Dihydrochalcone. Our commitment to excellence in manufacturing and supply ensures that our clients receive an ingredient that meets rigorous specifications. Whether you are innovating in the food industry, conducting critical biomedical research, or developing new pharmaceutical products, Naringin Dihydrochalcone offers a unique combination of sweetness and biological function. Partner with NINGBO INNO PHARMCHEM CO.,LTD. to harness the potential of this exceptional citrus-derived compound.
Perspectives & Insights
Nano Explorer 01
“The ease with which one can order Naringin Dihydrochalcone facilitates such scientific exploration.”
Data Catalyst One
“It has been shown to inhibit HMG-CoA reductase, a key enzyme in cholesterol synthesis, and ACAT enzymes involved in cholesterol esterification.”
Chem Thinker Labs
“These properties suggest potential health benefits, particularly in areas related to cardiovascular health and lipid management.”